Poniard Pharmaceuticals, Inc.
PARD · OTC
9/30/2011 | 6/30/2011 | 3/31/2011 | 12/31/2010 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $3 | $3 | $3 | $3 |
| SG&A Expenses | $3 | $3 | $3 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $1 |
| Operating Expenses | $4 | $4 | $3 | $5 |
| Operating Income | -$4 | -$4 | -$3 | -$5 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $4 | $4 | $3 | $5 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$4 | -$4 | -$3 | -$5 |
| % Margin | – | – | – | – |
| EPS | -2.4 | -2.8 | -2.4 | -4.09 |
| % Growth | 14.3% | -16.7% | 41.3% | – |
| EPS Diluted | -2.4 | -2.8 | -2.4 | -4.09 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$3 | -$4 | -$3 | -$4 |
| % Margin | – | – | – | – |